Over the last 12 months, the cell and gene therapy
manufacturing sphere has matured vastly with more companies advancing to
commercial products, especially with allogenic therapies. Now that the theory
behind the therapy is catching up with the technology, the two can come
together to progress towards producing commercial products.
Pharma IQ created a report on the cell and gene
manufacturing activity that is occurring across Europe regarding the road to
commercializing these therapies. Download this piece to learn more about what
clinical trials happening across Europe and what stage/ focus they are in.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.